URL details: ninlaroexperts.com/baseline-characteristics
URL title:
Real‐World Evidence for the NINLARO® (ixazomib) Regimen
URL description:
The NINLARO® (ixazomib) regimen has been investigated in patients with relapsed/refractory multiple myeloma in both randomized controlled trials and real‐world studies. This evidence can be used to complement data from clinical trials. See Important Safety and Prescribing Information.
URL last crawled:
2022-12-20
URL speed:
0.356 MB/s,
downloaded in 0.400 seconds
We found no external links pointing to this url.